(Q48398082)

11 February 2018

title

Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression. (English)

1 reference

11 February 2018

author

Ralitza Gueorguieva

2

1 reference

11 February 2018

author name string

Nashaat N Boutros

1

1 reference

11 February 2018

Ralph E Hoffman

3

1 reference

11 February 2018

Dan A Oren

4

1 reference

11 February 2018

Alan Feingold

5

1 reference

11 February 2018

Robert M Berman

6

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 December 2002

1 reference

11 February 2018

published in

Psychiatry Research

1 reference

11 February 2018

volume

113

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

245-254

1 reference

11 February 2018

Repetitive transcranial magnetic stimulation in the treatment of medication-resistant depression: preliminary data

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Electroencephalogram and repetitive transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Effects of coil design on delivery of focal magnetic stimulation. Technical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Transcranial magnetic stimulation: a novel antidepressive strategy?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals—preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

A controlled trial of daily left prefrontal cortex TMS for treating depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Transcranial magnetic stimulation (TMS) in controlled treatment studies: are some "sham" forms active?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900267-6

7 January 2021

10.1016/S0165-1781(02)00267-6

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

12559481

1 reference

11 February 2018